Provides a simplified, comprehensive overview of the complex molecular basis of prostate cancer

Emphasizes integrated molecular diagnostics

Offers a detailed focus on pathways of current interest, including specialized chapters on the EGFR pathway, the HER-2/neu pathway, and the androgen receptor pathways

Includes sections on pharmacogenomics and molecular classification

Contains chapters on functional imaging and the impact of molecularly targeted therapies on the U.S. FDA drug approval process

Designed specifically for practicing urologists, medical and radiation oncologists, as well as allied health pathologists, radiologists, and nurse oncologists